Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on May 21, 2007

Hypertension. 2007
Published online before print May 21, 2007, doi: 10.1161/HYPERTENSIONAHA.107.087577
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/1/103    most recent
HYPERTENSIONAHA.107.087577v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. M.
Right arrow Articles by Schnermann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. M.
Right arrow Articles by Schnermann, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAPTOPRIL
*FUROSEMIDE
*RENNIN
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Genetically altered mice

Submitted on January 15, 2007
Revised on February 6, 2007

Regulation of Renin Secretion and Expression in Mice Deficient in {beta}1- and {beta}2-Adrenergic Receptors

Soo Mi Kim; Limeng Chen; Robert Faulhaber-Walter; Mona Oppermann; Yuning Huang; Diane Mizel; Josephine P. Briggs; and Jurgen Schnermann*

From the National Institute of Diabetes and Digestive and Kidney Diseases (S.M.K., L.C., R.F-W., M.O., Y.H., D.M., J.S.), National Institutes of Health, Bethesda, Md; and the Howard Hughes Medical Institute (J.P.B.), Chevy Chase, Md.

* To whom correspondence should be addressed. E-mail: jurgens{at}intra.niddk.nih.gov.

Abstract--The present experiments were performed in {beta}1/{beta}2-adrenergic receptor-deficient mice ({beta}1/{beta}2ADR-/-) to assess the role of {beta}-adrenergic receptors in basal and regulated renin expression and release. On a control diet, plasma renin concentration (in ng angiotensin I per mL per hour), determined in tail vein blood, was significantly lower in {beta}1/{beta}2ADR-/- than in wild-type (WT) mice (222±65 versus 1456±335; P<0.01). Renin content and mRNA were 77% and 65±5% of WT. Plasma aldosterone (in picograms per mL) was also significantly reduced (420±36 in {beta}1/{beta}2ADR-/- versus 692±59 in WT). A low-salt diet (0.03%) for 1 week increased plasma renin concentration significantly in both {beta}1/{beta}2ADR-/- and WT mice (to 733±54 and 2789±555), whereas a high-salt diet (8%) suppressed it in both genotypes (to 85±24 in {beta}1/{beta}2ADR-/- and to 676±213 in WT). The absolute magnitude of salt-induced changes of plasma renin concentration was markedly greater in WT mice. Acute stimulation of renin release by furosemide, quinaprilat, captopril, or candesartan caused significant increases of plasma renin concentration in both {beta}1/{beta}2ADR-/- and WT mice, but again the absolute changes were greater in WT mice. We conclude that maintenance of normal levels of renin synthesis and release requires tonic {beta}-adrenergic receptor activation. In the chronic absence of {beta}-adrenergic receptor input, the size of the releasable renin pool decreases with a concomitant reduction in the magnitude of the plasma renin concentration changes caused by variations of salt intake or acute stimulation with furosemide, angiotensin-converting enzyme, or angiotensin type 1 receptor inhibition, but regulatory responsiveness is nonetheless maintained.


Key words: plasma renin • salt intake • aldosterone • furosemide • angiotensin-converting enzyme inhibition • candesartan • sympathetic nervous system




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Wagner, C. de Wit, M. Gerl, A. Kurtz, and K. Hocherl
Increased expression of cyclooxygenase 2 contributes to aberrant renin production in connexin 40-deficient kidneys
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1781 - R1786.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
F. Schweda, U. Friis, C. Wagner, O. Skott, and A. Kurtz
Renin Release
Physiology, October 1, 2007; 22(5): 310 - 319.
[Abstract] [Full Text] [PDF]